Poseida Therapeutics, Inc. (PSTX)

Poseida Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	30.55	44.47	81.38	206.33	83.97	87.78
Short-Term Investments	207.27	167.73	201.12	-	225.19	37.53
Cash & Short-Term Investments	237.81	212.2	282.49	206.33	309.15	125.32
Cash Growth	10.81%	-24.88%	36.92%	-33.26%	146.69%	312.30%
Receivables	12.43	9.01	9.09	-	-	-
Prepaid Expenses	4.1	1.5	2	2.71	2.58	0.88
Other Current Assets	-	3.76	4.98	4.84	2.26	0.98
Total Current Assets	254.34	226.48	298.56	213.87	314	127.18
Property, Plant & Equipment	37.72	40.78	46.67	48.23	48.32	10.86
Goodwill	4.23	4.23	4.23	4.23	4.23	4.23
Other Intangible Assets	1.32	1.32	1.32	1.32	1.32	1.32
Other Long-Term Assets	1.08	1.08	1.06	1.66	3.62	3.41
Total Assets	298.69	273.89	351.84	269.31	371.48	147
Accounts Payable	2.99	3.27	2.23	8.96	0.76	4.93
Accrued Expenses	25.82	27.7	22.18	21.05	22.62	12.26
Current Portion of Long-Term Debt	-	-	-	-	-	3
Current Portion of Leases	6.04	5.95	5.87	6.34	4.81	-
Current Unearned Revenue	63.29	31.01	19.72	4.5	-	-
Other Current Liabilities	4.3	3.4	3.89	2.49	1.84	1.67
Total Current Liabilities	102.43	71.32	53.89	43.34	30.03	21.86
Long-Term Debt	58.8	58.59	58.25	29.36	31.63	28.64
Long-Term Leases	18.82	20.88	24.64	25.5	25.37	-
Long-Term Unearned Revenue	54.92	16.78	25.33	13.26	23.76	19.59
Long-Term Deferred Tax Liabilities	-	-	-	0.06	0.06	0.06
Other Long-Term Liabilities	2.9	2.61	2.15	1.59	-1.33	2.92
Total Liabilities	237.87	170.18	164.24	113.1	109.52	73.06
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	710.83	697.86	658.6	563.06	543.84	2.69
Retained Earnings	-649.94	-594.29	-470.86	-406.86	-281.89	-152.22
Comprehensive Income & Other	-0.08	0.13	-0.15	-	0.01	0.02
Total Common Equity	60.82	103.7	187.6	156.21	261.97	-149.51
Shareholders' Equity	60.82	103.7	187.6	156.21	261.97	73.93
Total Liabilities & Equity	298.69	273.89	351.84	269.31	371.48	147
Total Debt	83.65	85.42	88.75	61.2	61.82	31.64
Net Cash (Debt)	154.16	126.78	193.74	145.13	247.34	93.68
Net Cash Growth	20.89%	-34.56%	33.50%	-41.32%	164.03%	728.35%
Net Cash Per Share	1.62	1.41	2.69	2.33	6.87	7.42
Filing Date Shares Outstanding	97.12	96.49	86.53	62.55	62.11	13.2
Total Common Shares Outstanding	97.08	95.64	85.96	62.52	61.86	13.2
Working Capital	151.9	155.16	244.68	170.54	283.97	105.32
Book Value Per Share	0.63	1.08	2.18	2.50	4.23	-11.33
Tangible Book Value	55.27	98.15	182.05	150.66	256.42	-155.06
Tangible Book Value Per Share	0.57	1.03	2.12	2.41	4.15	-11.75
Machinery	25.13	23.75	21.06	17.28	13.73	7.97
Construction In Progress	-	-	-	-	0.38	4.73
Leasehold Improvements	14.17	14.11	14.01	13.91	13.83	0.17

Source: S&P Capital IQ. Standard template. Financial Sources.